Clinical Trial Update: Clinical Significance of Heterozygosity for Mutations of the SLC12A3 Gene Coding for the Thiazide Sensitive Na-Cl Cotransporter [NA]

View source ↗

Summary

This completed clinical trial evaluated whether heterozygous mutations in SLC12A3, which encodes the thiazide-sensitive Na-Cl cotransporter, have clinical signi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gitelman Syndrome

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Heterozygous Carriers of Gitelman Syndrome | NA | Status: COMPLETED